James E Fritz - McCordsville IN Philip A Hipskind - New Palestine IN Stephen W Kaldor - Indianapolis IN Karen L Lobb - Indianapolis IN James A Nixon - Indianapolis IN
This invention provides a series of substituted propanamines useful as tachykinin receptor antagonists. This invention also provides methods employing these substituted propanamines as well as pharmaceutical formulations comprising these compounds.
2-Acylaminopropanamines As Tachykinin Receptor Antagonists
James E Fritz - McCordsville IN Philip A Hipskind - New Palestine IN Stephen W Kaldor - Indianapolis IN Karen L Lobb - Indianapolis IN James A Nixon - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31405
US Classification:
514415, 514412, 548455, 548504, 548506
Abstract:
This invention provides compounds of the Formula I: which are useful as tachykinin receptor antagonists. This invention also provides methods employing these compounds, as well as pharmaceutical formulations comprising these compounds.
Sung Y. Cho - Indianapolis IN Thomas A. Crowell - Indianapolis IN Bruce D. Gitter - Carmel IN Philip A. Hipskind - New Palestine IN J. Jeffry Howbert - Bellevue WA Karen L. Lobb - Indianapolis IN Brian S. Muehl - Indianapolis IN James A. Nixon - Indianapolis IN
This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
Piperidinyl And Piperazinyl Tachykinin Receptor Antagonists
Sung Y. Cho - Indianapolis IN Thomas A. Crowell - Indianapolis IN Bruce D. Gitter - Carmel IN Philip A. Hipskind - New Palestine IN J. Jeffry Howbert - Bellevue WA Karen L. Lobb - Indianapolis IN Brian S. Muehl - Indianapolis IN James A. Nixon - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31454
US Classification:
51425409, 514316, 514326, 544373, 546187, 546201
Abstract:
This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
Sung Y. Cho - Indianapolis IN, US Thomas A. Crowell - Indianapolis IN, US Bruce D. Gitter - Carmel IN, US Philip A. Hipskind - New Palestine IN, US J. Jeffry Howbert - Bellevue WA, US Karen L. Lobb - Indianapolis IN, US Brian S. Muehl - Indianapolis IN, US James A. Nixon - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K031/4045 C07D209/20
US Classification:
51425409, 514316, 514323, 544373, 546187, 546201
Abstract:
This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
Multicyclic Compounds For Use As Melanin Concentrating Hormone Antagonists In The Treatment Of Obesity And Diabetes
Jochen Ammenn - Hamburg, DE James Ronald Gillig - Indianapolis IN, US Lawrence Joseph Heinz - Pittsboro IN, US Philip Arthur Hipskind - New Palestine IN, US Michael Dean Kinnick - Indianapolis IN, US James Arthur Nixon - Indianapolis IN, US Carsten Ott - Bad Segeberg, DE Kenneth Allen Savin - Indianapolis IN, US Theo Schotten - Vierhoefen, DE Lawrence John Slieker - Carmel IN, US Nancy June Snyder - Lizton IN, US Michael Alan Robertson - Indianapolis IN, US
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
Thomas Britton - Carmel IN, US Robert Bruns - Carmel IN, US Buddy Cantrell - Fountaintown IN, US Philip Hipskind - New Palestine IN, US Karen Lobb - Indianapolis IN, US James Nixon - Indianapolis IN, US Paul Ornstein - Carmel IN, US Edward Smith - Indianapolis IN, US Hamideh Zarrinmayeh - Carmel IN, US Dennis Zimmerman - Zionsville IN, US Anne Nunes - Andover MA, US James Howbert - Bellevue WA, US
International Classification:
C07D235/02 A61K031/415 A01N043/52
US Classification:
548/304100, 548/310700, 514/393000
Abstract:
This invention provides a series of substituted benzimidazoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted benzimidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.
Thomas C. Britton - Carmel IN Robert F. Bruns - Carmel IN Donald R. Gehlert - Indianapolis IN Philip A. Hipskind - New Palestine IN Karen L. Lobb - Indianapolis IN James A. Nixon - Indianapolis IN Paul L. Ornstein - Carmel IN Edward C. R. Smith - Indianapolis IN Hamideh Zarrinmayeh - Carmel IN Dennis M. Zimmerman - Zionsville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31454 A61K 31404 C07D20912 C07D40106
US Classification:
5142352
Abstract:
This invention provides a series of substituted indoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides the novel substituted indoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these substituted indoles.
…I just wanted to introduce my audio team, James Nixon, Benson Lai, and Ansane(Anson Randal and Duane Perera). Situated across North America with locations in Edmonton AB, Canada, and Seattle, Washington, USA. We provide audio services from original compositions, sound design, arrangement, or...
News
As Brexit talks begin, Europe sees economic upswing over UK
The tables have turned somewhat, said James Nixon, chief European economist at Oxford Economics. The European economy is now enjoying a solid upswing and sentiment, especially towards the EU, is improving.
Date: Jun 20, 2017
Category: World
Source: Google
Europe gives go ahead for talks on third Greek bail-out
Their decision came as approval has been granted by politicians across the continent. James Nixon, chief economist at Oxford Economics, said: Miraculously, the pieces of a new bailout agreement for Greece fell into place this week.
Date: Jul 17, 2015
Category: World
Source: Google
Greek deal poisons Europe as backlash mounts against 'neo-colonial servitude'
Even if a deal can eventually be reached to keep Greece in the euro area, the ramifications of this weekends incredible bloodletting will have long-term consequences, said James Nixon from Oxford Economics.
"How do you persuade [European] government[s] to vote for a third bailout when the Greek government has actively campaigned in a referendum against the terms of a second bailout?" said James Nixon, chief European economist at Oxford Economics.
Date: Jul 01, 2015
Category: Business
Source: Google
ECB Warning to Greece Deploys Tactic Honed in Crisis
While these things might be threatened, bandied around,it would be remarkable if such a step were actually taken,said James Nixon, chief European economist at Oxford EconomicsLtd. in London. The negotiation starts off with the threat ofmutually assured destruction. But to actually withdraw fu
Date: Jan 13, 2015
Category: Business
Source: Google
Draghi Quest to Reach QE Consensus Starts With Asset Choice
The ECB may be realizing that the scenario of a gradual pickup in inflation is for the birds, said James Nixon, chief European economist at Oxford Economics Ltd. in London. Draghis concern could be that waiting two years for existing programs to work is just too risky.
Date: Nov 27, 2014
Category: Business
Source: Google
Draghi's Deflation Warning and the QE Obstacle Course
There are enormous political, legal and moral-hazard constraints, said James Nixon, an economist at Oxford Economics Ltd. in London. The euro area isnt a single, sovereign nation state. Thats a fundamental obstacle.
the Packers, linebackers Clay Matthews and Nick Perry both return from injury. Matthews will play with a cast on his injured arm. Quarterback Aaron Rodgers, wide receiver Chris Harper, cornerback James Nixon, linebacker Andy Mulumba, tackle Derek Sherrod, defensive end Josh Boyd and defensive end C.J.
Belmont Elementary School Philadelphia PA 1966-1968, Robert Lee Frost Elementary School 106 Indianapolis IN 1968-1972, J. K. Lilly School 53 Indianapolis IN 1972-1974, Heritage Christian High School Indianapolis IN 1974-1977
Community:
Russell Wing, Scott Camp, Jennifer Phillips, Deborah Goldsmith, Sonny Brunes, Alva Fisher
Eastern Connecticut State University - Communications
James Nixon
Work:
Freelance journalist
About:
Journalist, mostly into tech stuff, environmental issues, playing the mandolin, writing, film, eating cheese and riding my bike. Beard owns itself. Oh, and the gramophones. Don't forget the gramop...